Athanase Innovation (ATIN.ST) Stock Price

Athanase Innovation Price

OMX·CLOSED
20.60SEK+0.00 (+0.00 %)
Market closed

Revenue has compounded at 35.4% per year over the past 8 years to 115.27 M SEK. Earnings per share have grown at 191.6% per year over the last 3 years. Athanase Innovation's net margin stands at -17.0%, down from 49,257.2% several years earlier. Athanase Innovation currently offers a dividend yield of about 9.13%. The stock trades about 72% above its 52-week low.

Athanase Innovation stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Athanase Innovation over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Athanase Innovation stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Athanase Innovation's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Athanase Innovation Stock Price History
DateAthanase Innovation Price
8/4/202620.60 SEK
8/3/202620.60 SEK
7/30/202620.60 SEK
7/29/202620.60 SEK
7/28/202620.60 SEK
7/27/202620.60 SEK
7/24/202620.60 SEK
7/23/202620.60 SEK
7/22/202620.60 SEK
7/21/202620.60 SEK
7/20/202620.60 SEK
7/17/202620.80 SEK
7/16/202620.80 SEK
7/15/202620.00 SEK
7/14/202620.00 SEK
7/13/202620.00 SEK
7/10/202620.00 SEK
7/9/202618.30 SEK
7/8/202618.30 SEK
7/7/202618.30 SEK
7/6/202618.30 SEK
7/3/202618.30 SEK
7/2/202618.00 SEK
7/1/202618.00 SEK
6/30/202618.00 SEK
6/29/202618.00 SEK
6/26/202617.80 SEK
6/25/202617.80 SEK
6/24/202617.80 SEK
6/23/202615.10 SEK
6/22/202617.80 SEK
6/18/202617.80 SEK
6/17/202617.80 SEK
6/16/202617.30 SEK
6/15/202616.90 SEK
6/12/202616.90 SEK
6/11/202616.90 SEK
6/10/202616.90 SEK
6/9/202617.00 SEK
6/8/202617.00 SEK
6/5/202617.00 SEK
6/4/202617.00 SEK
6/3/202617.00 SEK
6/2/202617.00 SEK
6/1/202617.00 SEK
5/29/202617.00 SEK
5/28/202617.00 SEK
5/27/202617.00 SEK
5/26/202617.00 SEK
5/25/202617.00 SEK
5/22/202617.00 SEK
5/21/202617.00 SEK
5/20/202616.40 SEK
5/19/202616.40 SEK
5/18/202616.00 SEK
5/15/202616.00 SEK
5/13/202616.10 SEK
5/12/202616.10 SEK
5/11/202616.00 SEK
5/8/202616.20 SEK
5/7/202616.20 SEK
5/6/202616.20 SEK
5/5/202616.20 SEK
5/4/202614.40 SEK
4/30/202614.40 SEK
4/29/202614.40 SEK
4/28/202614.40 SEK
4/27/202614.40 SEK
4/24/202614.40 SEK
4/23/202614.70 SEK
4/22/202614.40 SEK
4/21/202614.40 SEK
4/20/202614.40 SEK
4/17/202614.40 SEK
4/16/202614.40 SEK
4/15/202614.40 SEK
4/14/202614.40 SEK
4/13/202614.40 SEK
4/10/202614.40 SEK
4/9/202614.40 SEK
4/8/202614.40 SEK
4/7/202614.40 SEK
4/2/202614.40 SEK
4/1/202614.40 SEK
3/31/202614.40 SEK
3/30/202614.40 SEK
3/27/202614.40 SEK
3/26/202614.40 SEK
3/25/202614.00 SEK
3/24/202614.00 SEK
3/23/202614.00 SEK
3/20/202614.20 SEK
3/19/202614.20 SEK
3/18/202615.90 SEK
3/17/202615.90 SEK
3/16/202615.90 SEK
3/13/202615.90 SEK
3/12/202612.00 SEK
3/11/202612.50 SEK
3/10/202612.50 SEK
3/9/202612.50 SEK
3/6/202612.90 SEK
3/5/202612.90 SEK
3/4/202612.90 SEK
3/3/202612.90 SEK
3/2/202612.90 SEK
2/27/202612.90 SEK
2/26/202613.90 SEK
2/25/202613.90 SEK
2/24/202613.90 SEK
2/23/202613.90 SEK
2/20/202613.90 SEK
2/19/202613.90 SEK
2/18/202613.90 SEK
2/17/202613.90 SEK
2/16/202613.90 SEK
2/13/202613.90 SEK
2/12/202613.90 SEK
2/11/202613.90 SEK
2/10/202612.00 SEK
2/9/202612.00 SEK
2/6/202612.00 SEK
2/5/202612.00 SEK
2/4/202612.00 SEK
2/3/202613.00 SEK
2/2/202612.00 SEK
1/30/202612.00 SEK
1/29/202612.00 SEK
1/28/202613.10 SEK
1/27/202613.10 SEK
1/26/202613.40 SEK
1/23/202613.40 SEK
1/22/202613.90 SEK
1/21/202613.90 SEK
1/20/202613.90 SEK
1/19/202613.90 SEK
1/16/202613.90 SEK
1/15/202613.90 SEK
1/14/202614.10 SEK
1/13/202614.10 SEK
1/12/202614.10 SEK
1/9/202615.00 SEK
1/8/202615.00 SEK
1/7/202613.90 SEK
1/5/202618.00 SEK
1/2/202618.00 SEK
12/30/202518.00 SEK
12/29/202518.00 SEK
12/23/202518.00 SEK
12/22/202518.00 SEK
12/19/202518.00 SEK
12/18/202518.00 SEK
12/17/202518.00 SEK
12/16/202518.00 SEK
12/15/202514.10 SEK
12/12/202514.10 SEK
12/11/202514.10 SEK
12/10/202514.10 SEK
12/9/202518.00 SEK
12/8/202518.00 SEK
12/5/202518.00 SEK
12/4/202518.00 SEK
12/3/202518.00 SEK
12/2/202518.00 SEK
12/1/202518.00 SEK
11/28/202518.00 SEK
11/27/202515.00 SEK
11/26/202515.00 SEK
11/25/202515.00 SEK
11/24/202515.00 SEK
11/21/202515.00 SEK
11/20/202515.00 SEK
11/19/202516.00 SEK
11/18/202516.80 SEK
11/17/202516.80 SEK
11/14/202516.80 SEK
11/13/202516.80 SEK
11/12/202516.80 SEK
11/11/202516.80 SEK
11/10/202516.80 SEK
11/7/202516.80 SEK
11/6/202516.80 SEK
11/5/202516.80 SEK
11/4/202516.80 SEK
11/3/202520.00 SEK
10/31/202520.00 SEK
10/30/202520.00 SEK
10/29/202520.00 SEK
10/28/202520.00 SEK
10/27/202520.00 SEK
10/24/202520.00 SEK
10/23/202520.00 SEK
10/22/202520.00 SEK
10/21/202520.00 SEK
10/20/202520.00 SEK
10/17/202520.00 SEK
10/16/202520.00 SEK
10/15/202520.00 SEK
10/14/202520.00 SEK
10/13/202520.00 SEK
10/10/202520.00 SEK
10/9/202520.00 SEK
10/8/202520.00 SEK
10/7/202517.10 SEK
10/6/202520.00 SEK
10/3/202520.00 SEK
10/2/202520.00 SEK
10/1/202520.00 SEK
9/30/202520.00 SEK
9/29/202518.10 SEK
9/26/202518.00 SEK
9/25/202521.60 SEK
9/24/202521.60 SEK
9/23/202521.60 SEK
9/22/202521.60 SEK
9/19/202521.60 SEK
9/18/202521.60 SEK
9/17/202521.60 SEK
9/16/202521.60 SEK
9/15/202521.60 SEK
9/12/202521.60 SEK
9/11/202521.60 SEK
9/10/202521.80 SEK
9/9/202518.00 SEK
9/8/202518.00 SEK
9/5/202518.00 SEK
9/4/202519.80 SEK
9/3/202519.80 SEK
9/2/202519.80 SEK
9/1/202519.80 SEK
8/29/202519.80 SEK
8/28/202519.80 SEK
8/27/202519.30 SEK
8/26/202519.00 SEK
8/25/202519.00 SEK
8/22/202520.60 SEK
8/21/202519.90 SEK
8/20/202519.90 SEK
8/19/202519.90 SEK
8/18/202519.90 SEK
8/15/202518.80 SEK
8/14/202518.80 SEK
8/13/202518.80 SEK
8/12/202518.80 SEK
8/11/202516.60 SEK
8/8/202516.60 SEK
Access this data via the Eulerpool API
Get Free API Key

Athanase Innovation Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2017
41.18 M SEK
19.74 M SEK
7.09 M SEK
Jan 1, 2018
42.03 M SEK
21.05 M SEK
6.30 M SEK
Jan 1, 2019
42.43 M SEK
20.91 M SEK
6.19 M SEK
Jan 1, 2020
352,300.00 SEK
-1.14 M SEK
173.53 M SEK
Jan 1, 2021
4.03 M SEK
-12.79 M SEK
-26.55 M SEK
Jan 1, 2022
6.38 M SEK
-129.16 M SEK
-114.53 M SEK
Jan 1, 2023
19.27 M SEK
-99.02 M SEK
-56.26 M SEK
Jan 1, 2024
115.27 M SEK
-79.40 M SEK
-19.64 M SEK

Athanase Innovation Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 7, 2026, 8:04 PM
 
REVENUEM SEK
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM SEK
EBITM SEK
EBIT MARGIN%
NET INCOMEM SEK
NET INCOME GROWTH%
DIV.SEK
DIV. GROWTH%
SHARESM
201620172018201920202021202220232024
10.0041.0042.0042.00–4.006.0019.00115.00
–310.002.44–––50.00216.67505.26
90.0097.5697.6297.62–1,025.00683.33215.7935.65
9.0040.0041.0041.0041.0041.0041.0041.0041.00
2.0019.0021.0020.00-1.00-12.00-129.00-99.00-79.00
20.0046.3450.0047.62–-300.00-2,150.00-521.05-68.70
-8.007.006.006.00173.00-26.00-114.00-56.00-19.00
–-187.50-14.29–2,783.33-115.03338.46-50.88-66.07
––120.327.527.521.88–––
–––-93.75–-75.00–––
0.190.190.190.190.1931.0431.0425.2519.30
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Athanase Innovation generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Athanase Innovation retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Athanase Innovation's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Athanase Innovation has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Athanase Innovation's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Athanase Innovation stock margins

The Athanase Innovation margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Athanase Innovation. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Athanase Innovation.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2017
97.89 %
47.94 %
17.22 %
Jan 1, 2018
97.79 %
50.08 %
14.99 %
Jan 1, 2019
97.55 %
49.28 %
14.59 %
Jan 1, 2020
97.55 %
-323.76 %
49,257.20 %
Jan 1, 2021
97.55 %
-317.37 %
-658.81 %
Jan 1, 2022
97.55 %
-2,024.20 %
-1,794.86 %
Jan 1, 2023
97.55 %
-513.79 %
-291.93 %
Jan 1, 2024
97.55 %
-68.88 %
-17.04 %

Athanase Innovation Stock Revenue, EBIT, Earnings per Share

The Athanase Innovation earnings per share therefore indicates how much revenue Athanase Innovation has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2017
216.74 SEK
103.89 SEK
37.32 SEK
Jan 1, 2018
221.21 SEK
110.79 SEK
33.16 SEK
Jan 1, 2019
223.32 SEK
110.05 SEK
32.58 SEK
Jan 1, 2020
1.88 SEK
-6.08 SEK
925.51 SEK
Jan 1, 2021
0.13 SEK
-0.41 SEK
-0.86 SEK
Jan 1, 2022
0.21 SEK
-4.16 SEK
-3.69 SEK
Jan 1, 2023
0.76 SEK
-3.92 SEK
-2.23 SEK
Jan 1, 2024
5.97 SEK
-4.11 SEK
-1.02 SEK

Athanase Innovation business model & stock analysis

Athanase Innovation Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Athanase Innovation historical P/E ratio, EBIT multiple, and P/S ratio

Athanase Innovation annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Athanase Innovation shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2017
190,000.00 Stocks
Jan 1, 2018
190,000.00 Stocks
Jan 1, 2019
190,000.00 Stocks
Jan 1, 2020
187,500.00 Stocks
Jan 1, 2021
31.04 M Stocks
Jan 1, 2022
31.04 M Stocks
Jan 1, 2023
25.25 M Stocks
Jan 1, 2024
19.30 M Stocks

Athanase Innovation stock splits

In Athanase Innovation's history, there have been no stock splits.

Athanase Innovation Dividend History

4 years of dividend payments

YearAnnual DividendYoY ChangePayments
20211.88SEK↓ 75.0%1×
20207.52SEK 0.0%4×
20197.52SEK 0.0%4×
20187.52SEK—4×

Athanase Innovation dividend payout ratio

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2017
248.46 %
Jan 1, 2018
362.96 %
Jan 1, 2019
369.42 %
Jan 1, 2020
13.00 %
Jan 1, 2021
-3,497.67 %
Jan 1, 2022
248.46 %
Jan 1, 2023
210.29 %
Jan 1, 2024
157.25 %
Price targets and forecasts for Athanase Innovation are not yet available.

Athanase Innovation shareholder structure

% Name
74.83109%
Athanase Industrial Partner AB
Athanase Industrial Partner AB
17.14435%
Avanza Bank Holding AB
Avanza Bank Holding AB
1.77015%
Knagenhielm Karlsson (Fredrik)
Knagenhielm Karlsson (Fredrik)
1.16337%
Alfred Berg Kapitalförvaltning AB
Alfred Berg Kapitalförvaltning AB
1.04331%
Jeansson (Theodor)
Jeansson (Theodor)
0.27689%
KEBEO Partner AB
KEBEO Partner AB

Athanase Innovation Beneficial Ownership Filings (SEC 13D/G)

Free Float
93.0%
Float Shares
-
Shares Outstanding
-

Athanase Innovation Executives and Management Board

4 members · avg. age 52 · 0 % women

Management

DE

Mr. Daniel Edeen

Acting Chief Executive Officer

–

Board of Directors

SC

Mr. Stefan Charette (52)

Chairman of the Board · since 2021

–
BJ

Mr. Bjoern Jeffrey

Director

–
VR

Mr. Vijay Ravindran

Director

–

Frequently asked questions about Athanase Innovation

Converted at the current exchange rate, the Athanase Innovation share trades at 1.88 EUR (20.60 SEK).

The Athanase Innovation share (ATIN.ST) is listed on 3 stock exchanges, including: Frankfurt (H6H.F).

No history available for Athanase Innovation.

The revenue cannot currently be calculated for Athanase Innovation.

The profit cannot currently be calculated for Athanase Innovation.

The P/E ratio cannot be calculated for Athanase Innovation at the moment.

The P/S cannot be calculated for Athanase Innovation currently.

The Eulerpool Quality Score for Athanase Innovation is 2/10.

The ISIN of Athanase Innovation is SE0018014060. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Athanase Innovation is A3DNBT. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Athanase Innovation is ATIN.ST. The ticker symbol is used to trade Athanase Innovation shares on the stock exchange.

The current dividend yield of Athanase Innovation is 9.13 %.

Athanase Innovation pays a dividend, distributed in the months of , , , .

Athanase Innovation paid dividends every year for the past 0 years.

Athanase Innovation is assigned to the 'Finance' sector.

To receive the latest dividend of Athanase Innovation from amounting to 1.88 SEK, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

The dividends of Athanase Innovation are distributed in SEK.

All fundamentals and in-depth analysis of Athanase Innovation

Our stock analysis for Athanase Innovation stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Athanase Innovation. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Athanase Innovation Stock
Athanase Innovation Revenue→
Athanase Innovation Stock
Athanase Innovation Net Income→
Athanase Innovation Stock
Athanase Innovation P/E→
Athanase Innovation Stock
Athanase Innovation P/S→
Athanase Innovation Stock
Athanase Innovation EBIT→
Athanase Innovation Stock
Athanase Innovation Dividend→
Athanase Innovation Stock
Athanase Innovation Directors Dealings→
Athanase Innovation Stock
Athanase Innovation Stocks→
Athanase Innovation Stock
Athanase Innovation Market capitalization→
Athanase Innovation Stock
Athanase Innovation Debt→
Athanase Innovation Stock
Athanase Innovation Liabilities→
Athanase Innovation Stock
Athanase Innovation Equity→
Athanase Innovation Stock
Athanase Innovation AAQS→
Athanase Innovation Stock
Athanase Innovation Employees→
Athanase Innovation Stock
Athanase Innovation ROE→
Athanase Innovation Stock
Athanase Innovation ROA→
Athanase Innovation Stock
Athanase Innovation ROCE→
Athanase Innovation Stock
Athanase Innovation News→
Athanase Innovation Stock
Athanase Innovation Analyst Price Targets→

Finance Stocks

Atinum Investment CoAtegrity Specialty Insurance Company HoldingsAtlantic AmericanASXAtlantic Union BanksharesAsuransi Tugu Pratama Indonesia Tbk PTAtlanticus HoldingsAsuransi Ramayana Tbk PTAtlantisAsuransi Multi Artha Guna Tbk PTAtlantis Technology GroupAsuransi Maximus Graha Persada Tbk PTAll Stocks A–Z →